Cardiologists and surgeons from the Smidt Heart Institute at Cedars-Sinai are available for interviews during Heart Month on an array of cardio-related topics.
Researchers at Children’s Hospital of Philadelphia (CHOP) have developed a custom-built application to automate determination of engraftment, a key outcome after hematopoietic stem cell transplant (HSCT). The application supersedes a tedious manual process and at the same time substantially improves accuracy of reported hematopoietic cell transplant engraftments.
The Stem Cell and Bone Marrow Transplant Program at Cedars-Sinai Cancer was recently recognized with two important hallmarks of quality: official accreditation for CAR T-cell therapy, and a third year in a row ranking among the top adult bone marrow transplant programs in the U.S.
Promising results from an ongoing clinical trial a three-drug treatment may improve survival in patients with newly diagnosed multiple myeloma who have undergone preliminary treatment followed by a stem cell transplant.
Credentialed press representatives are invited to attend The Society of Thoracic Surgeons’ 59th Annual Meeting and Exhibition, which will include late-breaking scientific research, thought-provoking lectures, cutting-edge technologies, and innovative cardiothoracic surgery products.
A change to Medicare policy surrounding heart transplant may lead to increased inequities in access to transplant for patients with heart failure, a new study finds. Results reveal that patients receiving Left Ventricular Assist Devices at transplant-capable centers had 79% higher odds to receive a bridge-to-transplant designation than patients treated at LVAD-only centers.
A new analysis by Cedars-Sinai investigators is furthering the scientific community’s understanding of COVID-19 immunity by showing that similar levels of COVID-19 antibodies are reached over an extended period of time in different population groups.
In a new study involving three volunteers, skin scars began to behave more like uninjured skin after they were treated with hair follicle transplants.
A new method of donor-lung distribution is projected to decrease the number of candidate deaths who are on the waitlist for lung transplant, according to a study by Cleveland Clinic and the U.S. Scientific Registry of Transplant Recipients (SRTR) published in The American Journal of Transplantation.
Peter Heeger, MD, Justin Steggerda, MD, Hirsh Trivedi, MD, and Lorenzo Zaffiri, MD, PhD, have all recently joined the Cedars-Sinai Comprehensive Transplant Center.
With the successful completion of back-to-back Christmas heart transplants, the University of Chicago Medicine set a new heart transplantation record for the state of Illinois, surpassing its own previous high-water mark for heart transplants. The Hyde Park-based academic health system has performed 66 heart transplants so far in 2022, surpassing last year's record of 61.
The Smidt Heart Institute at Cedars-Sinai welcomes four new specialists to its Department of Cardiology: interventional cardiologist Aakriti Gupta, MD, electrophysiologists Eric Braunstein, MD, and Archana Ramireddy, MD, and adult congenital cardiologist Prashanth Venkatesh, MD.
In people with active secondary progressive multiple sclerosis (MS), hematopoietic stem cell transplants may delay disability longer than some other MS medications, according to a study published in the December 21, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study involved autologous hematopoietic stem cell transplants, which use healthy blood stem cells from a person’s own body to replace diseased cells.
The University of Chicago Medicine transplant team performed the health system's first donated-after-circulatory death (DCD) heart transplant on Nov. 19, 2022. The DCD technique is expected to help heart patients get transplants faster. Donor hearts are traditionally recovered from brain-dead donors, a process known as donation after brain death (DBD).
New data show the University of Chicago Medicine's David and Etta Jonas Center for Cellular Therapy has the highest one-year survival rate in Illinois for adults undergoing blood and bone marrow stem cell transplants. UChicago Medicine had an 80% one-year survival rate among adult stem cell patients, according to the latest statistics released in mid-December by the Center for International Blood & Marrow Transplant Research (CIBMTR).
The Penn Transplant Institute at Penn Medicine has opened a new Center for Living Donation which will expand Penn’s exceptional care for living donors, helping to maximize the number of lives saved through liver and kidney transplantation. For the thousands waiting on a lifesaving organ, living donation—when a living person donates an organ, or part of an organ, for transplantation to another person—can help those in need receive life-saving care sooner.
The claim that a blood transfusion could pass on the inoculation from a vaccine is entirely false.
The world-renown journal Nature, named Muhammad Mohiuddin, MD, DSc, Program and Scientific Director of the Cardiac Xenotransplantation Program at the University of Maryland School of Medicine (UMSOM), on its annual list of 10 people who helped shaped science in 2022.
UC San Francisco surgeons have performed the health system’s 20,000th solid organ transplant, making it just the third in the nation to reach that milestone. The surgery also marked UCSF Health’s first donation after circulatory death (DCD) heart transplant, a procedure performed by only about twenty health systems in the U.S.
Researchers at The Tisch Cancer Institute at Mount Sinai have identified a treatment that is effective and safer than the standard of care for a serious, and sometimes fatal, side effect of bone marrow transplant in cancer patients. Results from a phase 2 clinical trial were presented at the annual meeting of the American Society of Hematology (ASH) in December.
UC San Diego Health has been named a Center of Excellence for polycystic kidney disease (PKD) by the PKD Foundation – the leading advocacy group dedicated to finding treatments and a cure for PKD. UC San Diego Health is one of just 28 institutions nationwide to receive this designation.
A new report on the ethics of crossing species boundaries by inserting human cells into nonhuman animals – research surrounded by debate – makes recommendations clarifying the ethical issues and calling for improved oversight of this work.
In a University of Michigan-led study, researchers found that most websites for heart transplant centers in the United States are difficult to understand, with more than 40% lacking information in languages other than English.
A woman experienced more than 25 cardiac arrests. Doctors placed her on ECMO, using "every trick" to keep her alive. Eventually, she was able to receive a heart transplant, leaving with a new outlook on life.
Analysis shows steep increases in organ donations, transplantations during large motorcycle rallies. The increase in organ donations and transplantations appears to be driven by well-documented increases in crash-related deaths during large motorcycle rallies.
This Thanksgiving, when the Moraleses think about what they’re thankful for, the Thompsons are at the top of the list.
With a new grant that brings together engineering expertise from Missouri S&T and medical expertise from Saint Louis University’s School of Medicine, researchers are investigating how artificial intelligence can support matchmaking between donated kidneys and transplant centers to help more patients in need.
American transplant centers as well as organ procurement organizations, the groups responsible for recovering organs from deceased donors in the United States, were less likely to accept or select organs from donors who were 70 years old when they died compared to those who were 69, new research found.
The recovery of Jesus Torres, a patient at Loyola Medicine with acute myeloid leukemia, highlights the importance of access to innovative, experimental treatments for blood cancers for all communities. As a world-class research institute, Loyola Medicine provides unique, life-saving therapies through its participation in clinical trials, such as a phase 3 clinical trial that uses umbilical cord blood transplantation to treat patients with acute myeloid leukemia.
Results of pancreas transplantation continue to improve and up to 90% of recipients with diabetes enjoy freedom from both insulin therapy and the need for close glucose monitoring following the procedure, according to a new paper published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
UMSOM Researchers Report on New Findings from Heart Monitoring Systems at American Heart Association Meeting
Here are some of the latest articles that have been added to the Arthritis channel on Newswise.
Pioneering research into the chronic inflammation often seen in certain blood cancers has identified a promising treatment approach for myelofibrosis, a potentially deadly bone marrow cancer.
The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented in-person and online at ASN Kidney Week 2022 November 3–November 6.
Insulin injections to treat Type 1 diabetes could become a thing of the past, but finding the cure faces many challenges. Although transplanting insulin-producing cells represents a promising approach, this cell therapy requires immunosuppression to prevent rejection. Georgia Tech researchers have developed a new biomaterial called iTOL-100 that could cure Type 1 diabetes by inducing immune acceptance of curative transplanted cells without immunosuppression.
SEATTLE — November 2, 2022 — Below are summaries of recent Fred Hutchinson Cancer Center research findings and other news.
For the first time in Illinois, surgeons at Northwestern Medicine’s Bluhm Cardiovascular Institute successfully transplanted a heart donated after circulatory death (DCD).
罗切斯特 ， 明尼苏达州 - 六十 前 ， ， 血液 骨髓 移植 只 种 尝试 救治血癌 试验性 疗法 ， 经过 年 发展 ， ， 如今 已然 种 重要 抗癌 手段。 当前 ， 医疗 医疗 医疗
Nas seis décadas em que o transplante de sangue e medula tem sido usado para tratar pacientes com câncer no sangue, esse tratamento experimental tornou-se uma ferramenta vital de combate ao câncer. A Mayo Clinic, em Rochester, Minnesota, está celebrando a marca de 10 mil transplantes sanguíneos e de medula usados para o tratamento de cânceres sanguíneos e de doenças relacionadas.
مدينة روتشستر، ولاية مينيسوتا. - على مدار الستة عقود الماضية منذ بداية استخدام عمليات زراعة الدم والنخاع لعلاج المرضى المصابين بسرطان الدم، أصبح هذا العلاج التجريبي أداة حيوية لمكافحة السرطان. تحتفل مايو كلينك في مدينة روتشستر بولاية مينيسوتا بإجراء 10,000 عملية زراعة دم ونخاع لعلاج سرطانات الدم والاضطرابات ذات الصلة.
En las seis décadas posteriores a que se comience a utilizar el trasplante de médula para tratar a pacientes con distintos tipos de cáncer de la sangre, este tratamiento, que en un principio fue experimental, se ha vuelto una herramienta vital para la lucha contra el cáncer. Mayo Clinic de Rochester (Minnesota) celebra el trasplante de sangre y médula ósea número 10 000 utilizado en el tratamiento de distintos tipos de cáncer de la sangre y trastornos relacionados.
Researchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) have used CRISPR/Cas9 technology to engineer donor T cells to try to treat seriously ill children with resistant leukemia, who had otherwise exhausted all available therapies.
A fault in cells that form a key part of the immune system can be repaired with a pioneering gene editing technique, finds new research demonstrated in human cells and mice, led by UCL scientists.
In 2019, two Canadian provinces passed deemed consent legislation, where adults are automatically presumed to consent to organ donation upon their death unless they registered to opt out.
Here are some of the latest articles that have been added to the Drugs and drug abuse channel.
UC San Diego Health is now offering a new treatment for patients with low-grade upper tract urothelial cancer that could safely avoid removal of the entire kidney, which may prevent the need for dialysis or kidney transplant in the future.
There is a small, but growing, subset of livers that have been transplanted and have a cumulative age of more than 100 years.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
